BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31469994)

  • 21. Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.
    Katayama S; Sueyoshi N; Inazu T; Kameshita I
    Neural Plast; 2020; 2020():6970190. PubMed ID: 32587608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with FRAX486 rescues neurobehavioral and metabolic alterations in a female mouse model of CDKL5 deficiency disorder.
    Fuchs C; Cosentino L; Urbinati C; Talamo MC; Medici G; Quattrini MC; Mottolese N; Pietraforte D; Fuso A; Ciani E; De Filippis B
    CNS Neurosci Ther; 2022 Nov; 28(11):1718-1732. PubMed ID: 35932179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo magnetic resonance spectroscopy in the brain of Cdkl5 null mice reveals a metabolic profile indicative of mitochondrial dysfunctions.
    Carli S; Chaabane L; Butti C; De Palma C; Aimar P; Salio C; Vignoli A; Giustetto M; Landsberger N; Frasca A
    J Neurochem; 2021 May; 157(4):1253-1269. PubMed ID: 33448385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnenolone and pregnenolone-methyl-ether rescue neuronal defects caused by dysfunctional CLIP170 in a neuronal model of CDKL5 Deficiency Disorder.
    Barbiero I; Peroni D; Siniscalchi P; Rusconi L; Tramarin M; De Rosa R; Motta P; Bianchi M; Kilstrup-Nielsen C
    Neuropharmacology; 2020 Mar; 164():107897. PubMed ID: 31794725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development.
    Van Bergen NJ; Massey S; Quigley A; Rollo B; Harris AR; Kapsa RMI; Christodoulou J
    Biochem Soc Trans; 2022 Aug; 50(4):1207-1224. PubMed ID: 35997111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. X-linked cellular mosaicism underlies age-dependent occurrence of seizure-like events in mouse models of CDKL5 deficiency disorder.
    Terzic B; Cui Y; Edmondson AC; Tang S; Sarmiento N; Zaitseva D; Marsh ED; Coulter DA; Zhou Z
    Neurobiol Dis; 2021 Jan; 148():105176. PubMed ID: 33197557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural Bases of Atypical Whisker Responses in a Mouse Model of CDKL5 Deficiency Disorder.
    Pizzo R; Lamarca A; Sassoè-Pognetto M; Giustetto M
    Neuroscience; 2020 Oct; 445():130-143. PubMed ID: 31472213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5.
    Tramarin M; Rusconi L; Pizzamiglio L; Barbiero I; Peroni D; Scaramuzza L; Guilliams T; Cavalla D; Antonucci F; Kilstrup-Nielsen C
    Hum Mol Genet; 2018 Jun; 27(12):2052-2063. PubMed ID: 29618004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder.
    Loi M; Bastianini S; Candini G; Rizzardi N; Medici G; Papa V; Gennaccaro L; Mottolese N; Tassinari M; Uguagliati B; Berteotti C; Martire VL; Zoccoli G; Cenacchi G; Trazzi S; Bergamini C; Ciani E
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder.
    Trazzi S; De Franceschi M; Fuchs C; Bastianini S; Viggiano R; Lupori L; Mazziotti R; Medici G; Lo Martire V; Ren E; Rimondini R; Zoccoli G; Bartesaghi R; Pizzorusso T; Ciani E
    Hum Mol Genet; 2018 May; 27(9):1572-1592. PubMed ID: 29474534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced hippocampal LTP but normal NMDA receptor and AMPA receptor function in a rat model of CDKL5 deficiency disorder.
    Simões de Oliveira L; O'Leary HE; Nawaz S; Loureiro R; Davenport EC; Baxter P; Louros SR; Dando O; Perkins E; Peltier J; Trost M; Osterweil EK; Hardingham GE; Cousin MA; Chattarji S; Booker SA; Benke TA; Wyllie DJA; Kind PC
    Mol Autism; 2024 Jun; 15(1):28. PubMed ID: 38877552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and Synaptic Bases of CDKL5 Disorder.
    Zhu YC; Xiong ZQ
    Dev Neurobiol; 2019 Jan; 79(1):8-19. PubMed ID: 30246934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic loss of cyclin-dependent kinase-like 5 recapitulates methylphenidate-remediable hyperlocomotion in mouse model of CDKL5 deficiency disorder.
    Jhang CL; Lee HY; Chen JC; Liao W
    Hum Mol Genet; 2020 Aug; 29(14):2408-2419. PubMed ID: 32588892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder.
    Fuchs C; Rimondini R; Viggiano R; Trazzi S; De Franceschi M; Bartesaghi R; Ciani E
    Neurobiol Dis; 2015 Oct; 82():298-310. PubMed ID: 26143616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder-related deficits.
    Terzic B; Davatolhagh MF; Ho Y; Tang S; Liu YT; Xia Z; Cui Y; Fuccillo MV; Zhou Z
    J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34651584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabidiol attenuates seizure susceptibility and behavioural deficits in adult CDKL5
    Li X; Yennawar M; Wiest A; O'Brien WT; Babrowicz B; White RS; Talos DM; Jensen FE
    Eur J Neurosci; 2024 Jun; 59(12):3337-3352. PubMed ID: 38654472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant mitochondrial function in patient-derived neural cells from CDKL5 deficiency disorder and Rett syndrome.
    Jagtap S; Thanos JM; Fu T; Wang J; Lalonde J; Dial TO; Feiglin A; Chen J; Kohane I; Lee JT; Sheridan SD; Perlis RH
    Hum Mol Genet; 2019 Nov; 28(21):3625-3636. PubMed ID: 31518399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDKL5-mediated developmental tuning of neuronal excitability and concomitant regulation of transcriptome.
    Liao W; Lee KZ
    Hum Mol Genet; 2023 Nov; 32(23):3276-3298. PubMed ID: 37688574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder?
    Barbiero I; De Rosa R; Kilstrup-Nielsen C
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of CDKL5 Causes Synaptic GABAergic Defects That Can Be Restored with the Neuroactive Steroid Pregnenolone-Methyl-Ether.
    De Rosa R; Valastro S; Cambria C; Barbiero I; Puricelli C; Tramarin M; Randi S; Bianchi M; Antonucci F; Kilstrup-Nielsen C
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.